[68Ga]FAPI-46

DRUG7 trials

Conditions

Breast cancerDuctal carcinoma in situFAPNon-resolving ARDSPDAC - Pancreatic Ductal AdenocarcinomaPeyronie's Diseasegiant cell arteritis - polymyalgia rheumatica spectrum diseaseinvasive lobular carcinomas of the breast

Phase 2

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

CompletedNCT05262855

SOFIEFAP, PDAC - Pancreatic Ductal Adenocarcinoma

Start: 2022-05-02End: 2025-11-04Updated: 2026-05-29

Multimodal Imaging with FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of occult Invasive cancer (MI-CISDIR)

Not yet recruitingCTIS2023-509860-47-00

Universitaet MuensterBreast cancer, Ductal carcinoma in situ

Target: 30Updated: 2025-05-20

68Ga-FAPI-46 PET for Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease

Not yet recruitingCTIS2024-511977-31-01

Universitair Medisch Centrum Groningengiant cell arteritis - polymyalgia rheumatica spectrum disease

Target: 30Updated: 2026-04-14

[68]GA-FAPI-46 PET/CT for the diagnosis of metastatic lesions in patients with lobular breast cancer (ICL). FAPICL

Not yet recruitingCTIS2025-524897-40-00

Hospices Civils De Lyoninvasive lobular carcinomas of the breast

Target: 45Updated: 2026-08-25

Phase 3

[68Ga]-FAPI PET/CT to detect fibroblast activity in non-resolving ARDS patients at the ICU.

Not yet recruitingCTIS2024-517257-27-00

Universitair Medisch Centrum GroningenNon-resolving ARDS

Target: 20Updated: 2024-10-18

LIBERATE; From Inflammation Biomarkers to Remodelling (FAPI PET/CT) towards personalized diagnosis in post-acute sequelae of COVID-19

RecruitingCTIS2024-517931-29-00

Universitair Medisch Centrum Groningenpost-acute sequelae of COVID-19

Start: 2025-07-01Target: 60Updated: 2025-09-22

Phase 4

Hippocrates; The use of FAPI-PET/CT and FDG-PET/CT scan in acute phase Peyronie’s disease for detection of active fibroblasts and inflammation in the penis - a pilot study

RecruitingCTIS2024-518838-82-00

Universitair Medisch Centrum GroningenPeyronie's Disease

Start: 2024-12-13Target: 20Updated: 2024-12-05

Related Papers

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol